Found: 48
Select item for more details and to access through your institution.
Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Neurocognitive dysfunction in adult cerebellar medulloblastoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The Alliance AMBUSH Trial: Rationale and Design.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 414, doi. 10.3390/cancers14020414
- By:
- Publication type:
- Article
Pediatric versus Adult Medulloblastoma: Towards a Definition That Goes beyond Age.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6313, doi. 10.3390/cancers13246313
- By:
- Publication type:
- Article
CATNON interim results: another triumph of upfront chemotherapy in glioma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 10, p. 1287, doi. 10.1093/neuonc/nox124
- By:
- Publication type:
- Article
An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 5, p. 669, doi. 10.1093/neuonc/now208
- By:
- Publication type:
- Article
Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. 252, doi. 10.1093/neuonc/now236
- By:
- Publication type:
- Article
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 2, p. 266, doi. 10.1093/neuonc/nou155
- By:
- Publication type:
- Article
Treatment, prognostic factors, and outcomes in spinal cord astrocytomas.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 4, p. 406, doi. 10.1093/neuonc/nos309
- By:
- Publication type:
- Article
Updates on Management of Adult Medulloblastoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Reply to Unexpectedly low rates of neuropsychiatric adverse effects associated with mefloquine repurposed for the treatment of glioblastoma.
- Published in:
- Cancer (0008543X), 2019, v. 125, n. 8, p. 1385, doi. 10.1002/cncr.31960
- By:
- Publication type:
- Article
Reply to Unexpectedly low rates of neuropsychiatric adverse effects associated with mefloquine repurposed for the treatment of glioblastoma.
- Published in:
- 2019
- By:
- Publication type:
- letter
Middle cerebral artery territory infarct due to C ryptococcus infection stitle.
- Published in:
- Diagnostic Cytopathology, 2015, v. 43, n. 8, p. 632, doi. 10.1002/dc.23219
- By:
- Publication type:
- Article
CBTRUS Statistical Report: American Brain Tumor Association & NCI Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016–2020.
- Published in:
- Neuro-Oncology, 2024, v. 26, p. iii1, doi. 10.1093/neuonc/noae047
- By:
- Publication type:
- Article
Rare central nervous system tumors: the path to progress.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. S1, doi. 10.1093/neuonc/noab144
- By:
- Publication type:
- Article
A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 8, p. 1337, doi. 10.1093/neuonc/noab040
- By:
- Publication type:
- Article
Letter to the Editor Re: Mohile et al.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 7, p. 1048, doi. 10.1093/neuonc/noaa109
- By:
- Publication type:
- Article
Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 601, doi. 10.1093/neuonc/noaa015
- By:
- Publication type:
- Article
Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 1, p. 106, doi. 10.1093/neuonc/noy091
- By:
- Publication type:
- Article
RTHP-22. RADIATION-INDUCED CENTRAL DEMYELINATION, A RARE SUBACUTE COMPLICATION IN 2 CASES.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi229, doi. 10.1093/neuonc/noy148.952
- By:
- Publication type:
- Article
ATIM-10. A PHASE I/II CLINICAL TRIAL OF AUTOLOGOUS CMV-SPECIFIC CYTOTOXIC T CELLS (CMV-TC) FOR GLIOBLASTOMA: DOSE ESCALATION AND CORRELATIVE RESULTS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi2, doi. 10.1093/neuonc/noy148.006
- By:
- Publication type:
- Article
ATIM-07. WINDOW-OF-OPPORTUNITY CLINICAL TRIAL OF PEMBROLIZUMAB IN RECURRENT GLIOBLASTOMA PATIENTS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi2, doi. 10.1093/neuonc/noy148.004
- By:
- Publication type:
- Article
ACTR-31. PHASE 1 STUDY OF AG-881, AN INHIBITOR OF MUTANT IDH1 AND IDH2: RESULTS FROM THE RECURRENT/PROGRESSIVE GLIOMA POPULATION.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi18, doi. 10.1093/neuonc/noy148.064
- By:
- Publication type:
- Article
ATIM-37. SAFETY RUN-IN RESULTS OF A PHASE I/II STUDY TO EVALUATE THE SAFETY AND CLINICAL EFFICACY OF ATEZOLIZUMAB (ATEZO; aPDL1) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) AND RADIATION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM).
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi9, doi. 10.1093/neuonc/noy148.032
- By:
- Publication type:
- Article
Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Dual inhibition of BRAF and mTOR in BRAF<sup>V600E</sup>-mutant pediatric, adolescent, and young adult brain tumors.
- Published in:
- Cold Spring Harbor Molecular Case Studies, 2020, v. 6, n. 4, p. 1, doi. 10.1101/mcs.a005041
- By:
- Publication type:
- Article
Exploring the prevalence and burden of sleep disturbance in primary brain tumor patients.
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 6, p. 526, doi. 10.1093/nop/npac049
- By:
- Publication type:
- Article
Montreal Cognitive Assessment (MoCA) in neuro-oncology: A pilot study of feasibility and utility in telehealth and in-person clinical assessments.
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 5, p. 429, doi. 10.1093/nop/npac038
- By:
- Publication type:
- Article
Living with a central nervous system (CNS) tumor: findings on long-term survivorship from the NIH Natural History Study.
- Published in:
- Neuro-Oncology Practice, 2021, v. 8, n. 4, p. 460, doi. 10.1093/nop/npab022
- By:
- Publication type:
- Article
Pineal parenchymal tumor of intermediate differentiation: a single-institution experience.
- Published in:
- Neuro-Oncology Practice, 2020, v. 7, n. 6, p. 613, doi. 10.1093/nop/npaa024
- By:
- Publication type:
- Article
Spinal cord compression in cancer patients: Review of diagnosis and treatment.
- Published in:
- Current Oncology Reports, 2008, v. 10, n. 1, p. 78, doi. 10.1007/s11912-008-0012-0
- By:
- Publication type:
- Article
Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: a case report.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1391-x
- By:
- Publication type:
- Article
Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: a case report.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma.
- Published in:
- Pituitary, 2016, v. 19, n. 4, p. 415, doi. 10.1007/s11102-016-0721-6
- By:
- Publication type:
- Article
Capturing evolving definitions of 12 select rare CNS tumors: a timely report from CBTRUS and NCI-CONNECT.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 165, n. 2, p. 279, doi. 10.1007/s11060-023-04480-7
- By:
- Publication type:
- Article
Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trial.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 162, n. 1, p. 137, doi. 10.1007/s11060-023-04271-0
- By:
- Publication type:
- Article
Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.
- Published in:
- Journal of Neuro-Oncology, 2021, v. 155, n. 3, p. 363, doi. 10.1007/s11060-021-03886-5
- By:
- Publication type:
- Article
The prevalence of altered body image in patients with primary brain tumors: an understudied population.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 147, n. 2, p. 397, doi. 10.1007/s11060-020-03433-8
- By:
- Publication type:
- Article
Rethinking medulloblastoma from a targeted therapeutics perspective.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 139, n. 3, p. 713, doi. 10.1007/s11060-018-2917-2
- By:
- Publication type:
- Article
NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 137, n. 1, p. 39, doi. 10.1007/s11060-017-2558-x
- By:
- Publication type:
- Article
NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 131, n. 1, p. 193, doi. 10.1007/s11060-016-2288-5
- By:
- Publication type:
- Article
A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 487, doi. 10.1007/s11060-016-2195-9
- By:
- Publication type:
- Article
Bevacizumab use in disseminated choroid plexus papilloma.
- Published in:
- 2013
- By:
- Publication type:
- Letter
PET-Florbetapir findings in primary cerebral amyloidoma.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Discovery of clinical and demographic determinants of symptom burden in primary brain tumor patients using network analysis and unsupervised clustering.
- Published in:
- Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdac188
- By:
- Publication type:
- Article
Proceedings of the Survivorship Care in Neuro-Oncology Workshop sponsored by the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT).
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac029
- By:
- Publication type:
- Article
Case Report: Single-Cell Transcriptomic Analysis of an Anaplastic Oligodendroglioma Post Immunotherapy.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.601452
- By:
- Publication type:
- Article
Treatment and long-term outcomes in pituitary carcinoma: a cohort study.
- Published in:
- European Journal of Endocrinology, 2019, v. 181, n. 4, p. 397, doi. 10.1530/EJE-18-0795
- By:
- Publication type:
- Article